Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Is Biotech Back In A Bull Market?

Published 08/20/2014, 07:09 AM
Updated 07/09/2023, 06:31 AM

Healthcare has been one of the leaders of the bull market that was born in 2009. Biotech in particular has seen some huge gains in certain stocks. Earlier in the year iShares Nasdaq Biotech (NASDAQ:IBB) got hammered on massive volume. It looked like the biotech bull took damage that it couldn't recover from. But the bounce back from April has been pretty impressive and biotech might be getting ready to make new highs here. The SPDR - Health Care (ARCA:XLV) ETF already made a new high so IBB might be right behind.

IBB

Furthermore some of the leading stocks in the healthcare and biotech sectors are making new highs and taking volume, further increasing the odds that this sector is resuming its uptrend.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.